Revisão crítica do tratamento medicamentoso da gota no Brasil tratamento da hiperuricemia e da artrite gotosa e especialmente para. Download Citation on ResearchGate | On Jan 1, , D. Cruz Niesvaara and others published Revisión y actualización de la hiperuricemia }. Download Citation on ResearchGate | On Jan 1, , Maria do Rosário and others published Dieta e Medicamentos no Tratamento da Hiperuricemia em.
| Author: | Vijind Fell |
| Country: | Luxembourg |
| Language: | English (Spanish) |
| Genre: | Career |
| Published (Last): | 7 August 2018 |
| Pages: | 281 |
| PDF File Size: | 12.95 Mb |
| ePub File Size: | 9.49 Mb |
| ISBN: | 802-5-93441-128-8 |
| Downloads: | 96009 |
| Price: | Free* [*Free Regsitration Required] |
| Uploader: | Gushicage |
Efeitos adversos no tratamento da tuberculose: Foram considerados como efeitos adversos maiores: Defaulting from anti-tuberculosis treatment in a teaching hospital in Rio de Janeiro, Brazil.
Int J Tuberc Lung Dis. Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis.
Risk factors for side-effects of isoniazid, rifampin and pyrazinamide in patients hospitalized for pulmonary tuberculosis. The dark side of antituberculosis therapy: Sociedade Brasileira de Pneumologia e Tisiologia. I Consenso Brasileiro de Tuberculose. The adverse reactions of anti-tuberculosis drugs and its management. Rio de Janeiro RJ: Sociedade Tratamneto de Pneumologia e Tisiologia; Adverse effects of antituberculosis drugs causing changes in treatment. Hepatotoxicity due to antituberculosis therapy.
Clinical profile and reintroduction of therapy. Toxic hepatitis with isoniazid and rifampin. A Hepatotoxicidade das Drogas Antituberculosas.
artrite gotosa ou gota: by Amanda Morais on Prezi
Controlled trial of 2, 4, and 6 months of pyrazinamide in 6-month, three-times-weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin, and pyrazinamide.
Results at 30 months. Am Rev Respir Dis. A controlled clinical comparison of 6 and 8 months of antituberculosis chemotherapy in the treatment of patients with silicotuberculosis in Hong Kong. Assessment of a daily combined preparation of isoniazid, rifampin, and pyrazinamide in a controlled trial of three 6-month regimens for smear-positive pulmonary tuberculosis. Denise Eri Onodera Vieira Av.
Portal Regional da BVS
All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License.
Services on Demand Journal.
SCS Quadra 1, Bl. How to cite this article.
